Stock Information

Hatay Pharmaceutical Joint Stock Company (HNX | Retail)

FINANCIAL RATIO »

Market Cap (VNDbn)

Outstanding shares (Shares)

BVS (VND)

EPS (VND)

P/E (Times)

P/B (Times)

EBIT (VNDbn)

EBITDA (VNDbn)

ROA (%)

ROE (%)

Debt/Total Assets

Gross Profit Margin (%)

Net Profit Margin (%)

Quick Ratio

Cash Ratio

Current Ratio

FINANCIAL DATA »

Peer Comparison

Ticker Price Change P/E P/B
DHT 0 -82,900 (-100.00) 87.14 6.33
Latest Update: 12:00 AM | 6/3/2025

Ownership structure

Major shareholder

Major Shareholder Rate %
Aska Pharmaceutical., Ltd 40.05%
Le Viet Linh 6.34%
Le Van Lo 5.61%
Hoang Van Tue 3.99%
Le Xuan Thang 3.89%

View more

Shareholder Documents

Document Name Date
Unaudited financial statements Q1 - 2025 28/04/2025
Audited financial statements Q6 - 2024 16/11/2024
Audited financial statements Year 2024 20/03/2025
Unaudited financial statements Q4 - 2024 19/02/2025
Unaudited financial statements Q3 - 2024 29/10/2024

Xem thêm